New Target Helps Enhance the Anti-tumor Response of Immunotherapy

Side effects/ toxicity of immunotherapy may be relieved by targeting interleukin-6 (IL-6) and immune checkpoint blockade while preserving anti-tumor immune response.

Related Keywords

Texas ,United States , ,University Of Texas Md Anderson Cancer Center ,Cancer Center ,Cancer ,Humor ,Immunotherapy ,Mmunotherapy Side Effects ,Immunotherapy Toxicity ,Immune Checkpoints ,Anti Tumor Response ,Immune Response ,